The most commonly prescribed GLP-1 RAs are: Semaglutide: Ozempic (type 2 diabetes), Wegovy (weight loss) Tirzepatide: Mounjaro (type 2 diabetes), Zepbound (weight loss) Dulaglutide: Trulicity (type 2 diabetes) Liraglutide: Victoza (type 2 diabetes), Saxenda (weight loss) According to the Endocrine Society, GLP-1 RAs promote early satiety, reduce food intake, and are associated with weight loss ( Endocr Pract , 2022)
Wegovy contains semaglutide for chronic weight management, while Ozempic is approved for type 2 diabetes and related indications
Medications like semaglutide and tirzepatide have shown promising results, leading to their use as weight-loss treatments and opening doors for millions struggling to achieve or maintain a healthy weight
The colours and doses are: green (Wegovy 0.25mg) pink (Wegovy 0.5mg) brown (Wegovy 1mg) blue (Wegovy 1.7mg) black (Wegovy 2.4mg) purple (Wegovy 7.2mg) Wegovy 0.25mg Wegovy 0.25mg comes with 4 doses of semaglutide 0.25mg
These medications work by slowing how the stomach empties and making people feel fuller, which can lead to eating smaller portions and cutting down on cravings
If they choose automated phone alerts on the application, they will also get an automated phone or text message